HHV8 Antikörper
-
- Target Alle HHV8 Produkte
- HHV8 (Herpes Virus Type 8 (HHV8))
-
Reaktivität
- Human
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HHV8 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität (Details)
- Species reactivity (tested):Human.
- Aufreinigung
- Purified
- Immunogen
- Recombinant protein corresponding to the latent nuclear antigen-1 molecule of HHV8.
- Klon
- LN53
- Isotyp
- IgG2c
-
-
- Applikationshinweise
-
Immunohistochemistry: Use at 1/25-1/50 dilution in an ABC method (30 to 60 minutes atroom temperature). Formalin fixed paraffin embedded tissue sections require high temperature antigenunmasking with 10 mM citrate buffer, pH 6.0 prior to immunostaining. Recommended Positive Control: Kaposi's sarcoma.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C.
-
- Target
- HHV8 (Herpes Virus Type 8 (HHV8))
- Andere Bezeichnung
- Herpes Virus Type 8 / HHV8 (HHV8 Produkte)
- Substanzklasse
- Virus
- Hintergrund
- HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.Synonyms: HHV-8, KHSV
-